Iron & ferroptosis Iron chelation
-
If levodopa treatment raises nigral iron levels, iron-chelation therapy becomes a candidate adjunct to counteract both disease-driven and drug-driven iron accumulation in the substantia nigra.
Published context: iron accumulation in the substantia nigra is linked to neurodegeneration and oxidative cell death; deferiprone and other chelators are in trials (FAIRPARK-II) to reduce this burden; levodopa-driven iron increase would strengthen the therapeutic rationale.